MET Amplification (MET/CEP7 Ratio ≥ 1.8) Is an Independent Poor Prognostic Marker in Patients With Treatment-naive Non-Small-cell Lung Cancer.
暂无分享,去创建一个
M. Guo | L. Medeiros | G. Toruner | G. Tang | Zhenya Tang | Shimin Hu | W. Yin | Joanne Cheng | Melissa Robinson